|
 Sandip B Tiwari, Ph.D., currently serving as head of technical services, pharma solutions at BASF Corporation, has been appointed vice chair of the American Association of Pharmaceutical Scientists (AAPS) In Vitro Release & Dissolution Testing Community for the year 2025. Dr Tiwari will succeed to the role of Chair in 2026, followed by Past Chair in 2027.
Dr Tiwari's extensive experience in pharmaceutical technical services and commitment to advancing industry standards made him an ideal candidate for this leadership position. The AAPS Board Communities Sub-Committee recognized his qualifications and the significant contributions he can make towards the goals of the AAPS.
In a letter addressed to Dr Tiwari, Amanda Hays, Ph.D., chair of the AAPS Board Communities Sub-Committee, expressed the committee's enthusiasm for his leadership role. "Your skills and experience will contribute greatly to the goals of AAPS and the community," Dr Hays noted in her correspondence.
Dr Tiwari will be undergoing mandatory leadership training in the upcoming year alongside other community leaders. This initiative aims to ensure effective collaboration and successful achievement of the organization's objectives.
The AAPS In Vitro Release & Dissolution Testing Community plays a crucial role in enhancing pharmaceutical research, particularly in the evaluation and standardization of drug release methodologies. With the expertise and leadership of Dr Tiwari, the community looks forward to achieving new milestones in the field.
BASF is a global leader in chemicals, and its pharma solutions division provides a wide range of products and technical services aimed at improving drug formulation and delivery.
The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific organization of more than 7,000 members worldwide, dedicated to the advancement of pharmaceutical sciences and research.
|